Ask Us
Safety Alert: Carbamazepine
Apotex Corp.Recalls Single Lot of Carbamazepine Tablets 200 mg
What does this mean?
This recall for Carbamazepine Tablets 200 mg from Apotex was issued at a warehouse and pharmacy level only. The FDA and the manufacturer have determined that any recalled product that may have been dispensed to patients does not pose a significant health risk. If you take Carbamazepine Tablets 200 mg and are concerned, you should consult with your physician.
Apotex Corp. has recalled a single lot of Carbamazepine Tablets 200 mg. Lot number JD2135 has been recalled because routine testing found that tablets in this lot may contain impurities.
Carbamazepine is used in the treatment of epilepsy and trigeminal neuralgia. It is also sometimes used to treat mania, bipolar disorder, and other mood disorders. Carbamazepine is also sold under several different brand names. This recall alert only applies to the single lot of the generic Carbamazepine Tablets 200 mg made by Apotex. No other Carbamazepine products were involved in this recall.
To view the FDA notice about this recall, please visit:
